In 2023, beta-blocking medicine sales in Italy stood at $7.0 per capita. The forecast for 2024 to 2028 shows a slight growth trend from $7.1 in 2024 to $7.3 in 2028, indicating a modest year-on-year increase of around 0.7% for 2025 and 2027, and nearly 1.4% for 2026 and 2028. The compound annual growth rate (CAGR) over this period is approximately 0.7%, highlighting a stable market with minimal fluctuations.

Future trends to watch for:

Increased adoption of personalized medicine could drive changes in beta-blocker usage patterns.
Emerging generic alternatives might affect market dynamics and pricing strategies.
Enhanced awareness of cardiovascular health could influence demand.